Allergic Reason 5 O O
reactions Reason 5 O O
to Reason 5 O O
COVID-19 Reason 5 O O
mRNA Reason 5 O O
vaccines Reason 5 O O
are Reason 5 O O
rare Reason 5 O O
and Reason 5 O O
usually Reason 5 O O
mild, Reason 5 O O
according Reason 5 O O
to Reason 5 O O
a Reason 5 O O
[study](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2784268) Reason 5 O O
late O O O O
last O O O O
week O O O O
in O O O O
JAMA O O O O
Network O O O O
Open. O O O O
Stanford Reason 5 ScientificAuthority O
University Reason 5 ScientificAuthority O
researchers Reason 5 O O
led Reason 5 O O
the Reason 5 O O
study Reason 5 O O
of Reason 5 O O
22 Reason 5 O O
reported Reason 5 O O
allergic Reason 5 O O
reactions Reason 5 O O
to Reason 5 O O
the Reason 5 O O
first Reason 5 O O
38,895 Reason 5 O O
doses Reason 5 O O
of Reason 5 O O
the Reason 5 O O
Pfizer/BioNTech Reason 5 O O
and Reason 5 O O
Moderna Reason 5 O O
COVID-19 Reason 5 O O
vaccines Reason 5 O O
given Reason 5 O O
to Reason 5 O O
healthcare Reason 5 O O
workers Reason 5 O O
from Reason 5 O O
Dec Reason 5 O O
18, Reason 5 O O
2020, Reason 5 O O
to Reason 5 O O
Jan Reason 5 O O
26, Reason 5 O O
2021 Reason 5 O O
(less Reason 5 O O
than Reason 5 O O
six Reason 5 O O
hundredths Reason 5 O O
of Reason 5 O O
a Reason 5 O O
percent). Reason 5 O O
Of Reason 5 O O
all Reason 5 O O
vaccinations, Reason 5 O O
80.6% Reason 5 O O
were Reason 5 O O
of Reason 5 O O
the Reason 5 O O
Pfizer Reason 5 O O
vaccine, Reason 5 O O
while Reason 5 O O
18.7% Reason 5 O O
were Reason 5 O O
of Reason 5 O O
Moderna. Reason 5 O O
The Reason 5 O O
study Reason 5 O O
population Reason 5 O O
was Reason 5 O O
60% Reason 5 O O
women, Reason 5 O O
64% Reason 5 O O
White, Reason 5 O O
2% Reason 5 O O
Black, Reason 5 O O
20% Reason 5 O O
Asian, Reason 5 O O
16% Reason 5 O O
younger Reason 5 O O
than Reason 5 O O
50 Reason 5 O O
years, Reason 5 O O
and Reason 5 O O
54% Reason 5 O O
aged Reason 5 O O
70 Reason 5 O O
and Reason 5 O O
older. Reason 5 O O
According Reason 5 O O
to Reason 5 O O
the Reason 5 O O
national Reason 5 O O
[Vaccine Reason 5 O O
Adverse Reason 5 O O
Event Reason 5 O O
Reporting Reason 5 O O
System](https://vaers.hhs.gov/) Reason 5 O O
(VAERS), Reason 5 O O
the Reason 5 O O
rate Reason 5 O O
of Reason 5 O O
severe Reason 5 O O
vaccine-related Reason 5 O O
anaphylaxis, Reason 5 O O
or Reason 5 O O
a Reason 5 O O
serious Reason 5 O O
allergic Reason 5 O O
reaction Reason 5 O O
that Reason 5 O O
requires Reason 5 O O
hospitalization, Reason 5 O O
is Reason 5 O O
4.7 Reason 5 O O
per Reason 5 O O
million Reason 5 O O
for Reason 5 O O
the Reason 5 O O
Pfizer Reason 5 O O
vaccine Reason 5 O O
and Reason 5 O O
2.5 Reason 5 O O
per Reason 5 O O
million Reason 5 O O
for Reason 5 O O
Moderna. Reason 5 O O
But O O O O
the O O O O
authors O O O O
noted O O O O
that O O O O
VAERS O O O O
tends O O O O
not O O O O
to O O O O
capture O O O O
mild O O O O
or O O O O
moderate O O O O
allergic O O O O
reactions O O O O
to O O O O
vaccines. O O O O
Women O O O O
at O O O O
higher O O O O
risk O O O O
for O O O O
allergy O O O O
Of O O O O
the O O O O
22 O O O O
allergic O O O O
reactions O O O O
occurring O O O O
within O O O O
3 O O O O
hours O O O O
of O O O O
receiving O O O O
a O O O O
vaccine O O O O
dose, O O O O
20 O O O O
occurred O O O O
in O O O O
women. O O O O
Symptoms O O O O
indicating O O O O
a O O O O
possible O O O O
allergic O O O O
reaction O O O O
included O O O O
hives; O O O O
swelling O O O O
of O O O O
the O O O O
mouth, O O O O
lips, O O O O
tongue, O O O O
or O O O O
throat; O O O O
shortness O O O O
of O O O O
breath, O O O O
wheezing, O O O O
or O O O O
chest O O O O
tightness; O O O O
and O O O O
changes O O O O
in O O O O
blood O O O O
pressure O O O O
or O O O O
loss O O O O
of O O O O
consciousness. O O O O
Seventeen Reason 3 O O
of Reason 3 O O
the Reason 3 O O
22 Reason 3 O O
reactions Reason 3 O O
met Reason 3 O O
the Reason 3 O O
diagnostic Reason 3 O O
criteria Reason 3 O O
for Reason 3 O O
likely Reason 3 O O
anaphylaxisThree Reason 3 O O
vaccinees Reason 3 O O
received Reason 3 O O
epinephrine, Reason 3 O O
a Reason 3 O O
drug Reason 3 O O
typically Reason 3 O O
given Reason 3 O O
for Reason 3 O O
severe Reason 3 O O
anaphylaxis. Reason 3 O O
All Reason 3 O O
patients Reason 3 O O
recovered. Reason 3 O O
Fifteen O O O O
of O O O O
the O O O O
22 O O O O
vaccinees O O O O
with O O O O
allergic O O O O
reactions O O O O
had O O O O
a O O O O
history O O O O
of O O O O
allergy O O O O
to O O O O
antibiotics O O O O
(10), O O O O
foods O O O O
(9), O O O O
medications O O O O
excluding O O O O
antibiotics O O O O
(8), O O O O
or O O O O
a O O O O
combination O O O O
of O O O O
these. O O O O
Five O O O O
patients O O O O
had O O O O
a O O O O
history O O O O
of O O O O
anaphylaxis, O O O O
3 O O O O
of O O O O
them O O O O
to O O O O
antibiotics, O O O O
1 O O O O
to O O O O
pork, O O O O
and O O O O
1 O O O O
to O O O O
peanuts. O O O O
Current O O O O
Centers O O ScientificAuthority O
for O O ScientificAuthority O
Disease O O ScientificAuthority O
Control O O ScientificAuthority O
and O O ScientificAuthority O
Prevention O O ScientificAuthority O
guidelines O O O O
advise O O O O
anyone O O O O
who O O O O
had O O O O
a O O O O
severe O O O O
allergic O O O O
reaction O O O O
to O O O O
any O O O O
component O O O O
or O O O O
the O O O O
first O O O O
dose O O O O
of O O O O
either O O O O
mRNA O O O O
COVID-19 O O O O
vaccine O O O O
to O O O O
avoid O O O O
further O O O O
exposure O O O O
to O O O O
it. O O O O
Opportunities O O O O
for O O O O
vaccine O O O O
reformulation O O O O
In O O O O
follow-up O O O O
basophil O O O O
activation O O O O
testing, O O O O
10 O O O O
of O O O O
11 O O O O
vaccinee O O O O
blood O O O O
samples O O O O
reacted O O O O
to O O O O
the O O O O
inert O O O O
vaccine O O O O
ingredient O O O O
polyethylene O O O O
glycol O O O O
(PEG), O O O O
which O O O O
is O O O O
used O O O O
in O O O O
both O O O O
the O O O O
Pfizer O O O O
and O O O O
Moderna O O O O
vaccines O O O O
(none O O O O
tested O O O O
positive O O O O
via O O O O
skin O O O O
prick O O O O
test). O O O O
Because Reason 4 O O
all Reason 4 O O
11 Reason 4 O O
vaccinees Reason 4 O O
had Reason 4 O O
antibodies Reason 4 O O
against Reason 4 O O
PEG Reason 4 O O
in Reason 4 O O
their Reason 4 O O
blood, Reason 4 O O
the Reason 4 O O
authors Reason 4 O O
said Reason 4 O O
that Reason 4 O O
they Reason 4 O O
were Reason 4 O O
probably Reason 4 O O
already Reason 4 O O
sensitive Reason 4 O O
to Reason 4 O O
it Reason 4 O O
from Reason 4 O O
previous Reason 4 O O
exposure. Reason 4 O O
"What's Reason 4 O O
important Reason 4 O O
is Reason 4 O O
what Reason 4 O O
we Reason 4 O O
didn't Reason 4 O O
find, Reason 4 O O
as Reason 4 O O
much Reason 4 O O
as Reason 4 O O
what Reason 4 O O
we Reason 4 O O
did Reason 4 O O
find," Reason 4 O O
senior Reason 4 O O
study Reason 4 O O
author Reason 4 O O
Kari Reason 4 O O
Nadeau, Reason 4 O O
MD, Reason 4 O O
PhD, Reason 4 O O
said Reason 4 O O
in Reason 4 O O
a Reason 4 O O
Stanford Reason 4 ScientificAuthority O
Medicine Reason 4 ScientificAuthority O
[press Reason 4 ScientificAuthority O
release](https://www.eurekalert.org/news-releases/928860). Reason 4 ScientificAuthority O
"It Reason 4 O O
does Reason 4 O O
not Reason 4 O O
seem Reason 4 O O
that Reason 4 O O
the Reason 4 O O
mRNA Reason 4 O O
itself Reason 4 O O
causes Reason 4 O O
the Reason 4 O O
allergic Reason 4 O O
reactions." Reason 4 O O
The Reason 4 O O
study Reason 4 O O
results Reason 4 O O
also Reason 4 O O
suggest Reason 4 O O
that Reason 4 O O
the Reason 4 O O
reactions Reason 4 O O
were Reason 4 O O
mediated Reason 4 O O
by Reason 4 O O
immunoglobulin Reason 4 O O
G Reason 4 O O
(IgG) Reason 4 O O
antibodies Reason 4 O O
and Reason 4 O O
basophils, Reason 4 O O
which Reason 4 O O
are Reason 4 O O
typically Reason 4 O O
managed Reason 4 O O
with Reason 4 O O
antihistamines, Reason 4 O O
fluids, Reason 4 O O
corticosteroids, Reason 4 O O
and Reason 4 O O
observation. Reason 4 O O
This Reason 5 O O
means Reason 5 O O
that Reason 5 O O
many Reason 5 O O
vaccinees Reason 5 O O
who Reason 5 O O
had Reason 5 O O
allergic Reason 5 O O
reactions Reason 5 O O
to Reason 5 O O
the Reason 5 O O
first Reason 5 O O
dose Reason 5 O O
will Reason 5 O O
be Reason 5 O O
able Reason 5 O O
to Reason 5 O O
safely Reason 5 O O
receive Reason 5 O O
the Reason 5 O O
second Reason 5 O O
dose Reason 5 O O
under Reason 5 O O
medical Reason 5 O O
supervision, Reason 5 O O
the Reason 5 O O
researchers Reason 5 O O
said. Reason 5 O O
"It's Reason 5 O O
nice Reason 5 O O
to Reason 5 O O
know Reason 5 O O
these Reason 5 O O
reactions Reason 5 O O
are Reason 5 O O
manageable," Reason 5 O O
Nadeau Reason 5 O O
said. Reason 5 O O
"Having Reason 5 O O
an Reason 5 O O
allergic Reason 5 O O
reaction Reason 5 O O
to Reason 5 O O
these Reason 5 O O
new Reason 5 O O
vaccines Reason 5 O O
is Reason 5 O O
uncommon, Reason 5 O O
and Reason 5 O O
if Reason 5 O O
it Reason 5 O O
does Reason 5 O O
happen, Reason 5 O O
there's Reason 5 O O
a Reason 5 O O
way Reason 5 O O
to Reason 5 O O
manage Reason 5 O O
it." Reason 5 O O
The Reason 5 O O
study Reason 5 O O
also Reason 5 O O
suggests Reason 5 O O
how Reason 5 O O
vaccine Reason 5 O O
makers Reason 5 O O
can Reason 5 O O
reformulate Reason 5 O O
the Reason 5 O O
vaccines Reason 5 O O
to Reason 5 O O
make Reason 5 O O
them Reason 5 O O
less Reason 5 O O
allergenic, Reason 5 O O
Nadeau Reason 5 O O
said. Reason 5 O O
PEG O O O O
is O O O O
a O O O O
common O O O O
ingredient O O O O
in O O O O
household O O O O
products, O O O O
cosmetics, O O O O
and O O O O
medications, O O O O
to O O O O
which O O O O
women O O O O
likely O O O O
have O O O O
broader O O O O
exposure O O O O
than O O O O
men, O O O O
the O O O O
researchers O O O O
said. O O O O
This O O O O
not O O O O
only O O O O
could O O O O
explain O O O O
the O O O O
sex O O O O
difference O O O O
in O O O O
vaccine O O O O
reactions, O O O O
but O O O O
it O O O O
could O O O O
also O O O O
allow O O O O
manufacturers O O O O
to O O O O
reformulate O O O O
the O O O O
vaccines O O O O
with O O O O
less O O O O
allergenic O O O O
stabilizers. O O O O
"If Reason 4 O O
confirmed Reason 4 O O
by Reason 4 O O
more Reason 4 O O
systematic Reason 4 O O
future Reason 4 O O
investigations, Reason 4 O O
these Reason 4 O O
findings Reason 4 O O
highlight Reason 4 O O
potential Reason 4 O O
opportunities Reason 4 O O
for Reason 4 O O
patient Reason 4 O O
risk Reason 4 O O
stratification Reason 4 O O
and Reason 4 O O
for Reason 4 O O
alternatives Reason 4 O O
in Reason 4 O O
vaccine Reason 4 O O
manufacturing; Reason 4 O O
furthermore, Reason 4 O O
they Reason 4 O O
can Reason 4 O O
inform Reason 4 O O
ongoing Reason 4 O O
mRNA Reason 4 O O
vaccine Reason 4 O O
development, Reason 4 O O
including Reason 4 O O
that Reason 4 O O
of Reason 4 O O
possible Reason 4 O O
COVID-19 Reason 4 O O
booster Reason 4 O O
shots Reason 4 O O
to Reason 4 O O
protect Reason 4 O O
against Reason 4 O O
emerging Reason 4 O O
disease Reason 4 O O
variants," Reason 4 O O
the Reason 4 O O
authors Reason 4 O O
concluded. Reason 4 O O
